Sectoral Asset Management’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$902K Sell
22,140
-10,545
-32% -$389K 0.75% 33
2025
Q4
$1.16M Buy
+32,685
New +$919K 0.93% 33
2025
Q2
Sell
-79,020
Closed -$473K 98
2025
Q1
$473K Buy
79,020
+5,220
+7% +$40.9K 0.37% 55
2024
Q4
$576K Sell
73,800
-10,600
-13% -$106K 0.38% 54
2024
Q3
$912K Sell
84,400
-1,200
-1% -$11.7K 0.54% 52
2024
Q2
$722K Sell
85,600
-178,100
-68% -$1.35M 0.29% 58
2024
Q1
$1.77M Buy
+263,700
New +$1.63M 0.7% 45
2021
Q3
Sell
-27,000
Closed -$219K 129
2021
Q2
$219K Hold
27,000
0.02% 125
2021
Q1
$237K Buy
+27,000
New +$260K 0.02% 110
2020
Q1
Sell
-36,686
Closed -$106K 68
2019
Q4
$106K Sell
36,686
-343,108
-90% -$1.4M 0.02% 65
2019
Q3
$2.19M Sell
379,794
-17,065
-4% -$139K 0.38% 52
2019
Q2
$4.16M Hold
396,859
0.5% 57
2019
Q1
$6.97M Buy
396,859
+84,323
+27% +$1.44M 0.84% 44
2018
Q4
$5.5M Buy
312,536
+50,800
+19% +$1.5M 0.75% 47
2018
Q3
$10.8M Sell
261,736
-8,650
-3% -$488K 1.14% 32
2018
Q2
$15.5M Hold
270,386
1.74% 24
2018
Q1
$12M Buy
+270,386
New +$12M 1.32% 28

Other funds holding COGT

Sectoral Asset Management's COGT Position: Q1 2026 in Review

Sectoral Asset Management reduced its Cogent Biosciences (COGT) stake by 32% in Q1 2026, selling an estimated $389K and leaving 22,140 shares worth $902K. The position accounts for 0.75% of the portfolio, ranked #33.

Sectoral Asset Management first reported a position in COGT in Q1 2018 and has held it in 17 quarters since. The position peaked at $15.5M in Q2 2018. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Sectoral Asset Management held 22,140 shares of Cogent Biosciences worth $902K as of Q1 2026.
  • Sectoral Asset Management sold 10,545 Cogent Biosciences shares in Q1 2026, an estimated $389K.
  • Cogent Biosciences made up 0.75% of Sectoral Asset Management's portfolio in Q1 2026, its #33 holding.
  • Sectoral Asset Management first reported a position in Cogent Biosciences in Q1 2018 and has held it in 17 quarters since.
  • Sectoral Asset Management's Cogent Biosciences position peaked at $15.5M in Q2 2018.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Sectoral Asset Management's 13F filing for Q1 2026, filed 15 May 2026.